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INTRODUCTION
Evidence is accumulating that CD4+ lymphocytes with a
T-helper 2 (Th2) cytokine pattern play an important role in
the pathogenesis of asthma (1). These cells orchestrate the
recruitment and activation of the primary effector cells of
the allergic response (mast cells and eosinophils), through
the release of cytokines such as interleukin (IL)-4, IL-5, and
IL-13. CD4+ T cells secrete a characteristic series of lym-
phokines, including IL-2, which is a growth factor that stim-
ulates the clonal expansion of T cells, and interferon (IFN)- ,
which is an important mediator of macrophage activation
during Mycobacterium tuberculosis infection (2). The balance
between the two T-cell subsets is important for allergic sen-
sitization. T-helper 1 (Th1) cells activate mononuclear phago-
cytes that are involved in cell-mediated immunity, while
Th2 cells dominate asthma and allergic diseases (3).
Shirakawa et al. (4) reported that a positive tuberculin
response in bacillus Calmette-Guerin (BCG)-vaccinated
schoolchildren in Japan correlated with a lower incidence of
atopic disorders. Th1 cells secreting IFN- regulate Th2
cells and may be involved in down-regulating the Th2-driv-
en airway hyperreactivity and asthma.
Regulatory CD4+ T cells (Tr) appear to control the devel-
opment of asthma and allergy. To date, four major types of
Tr have been found: Th3 cells, Tr cells, CD4+CD25+ cells,
and natural killer T cells (5). Either TGF- or IL-10 has
regulatory or suppressive properties that inhibit the effects
of pathogenic autoreactive T cells (6). The mechanisms that
protect against the development of allergic disease and asth-
ma are not fully understood.
The authors are unaware of any data that have been pub-
lished investigating Th1, Th2, and regulatory cytokines in
patients with both Th2-type asthma and Th1-type active
pulmonary tuberculosis. Therefore, we analyzed the tuber-
culin response and atopy through the Th1 and Th2 immune
status in patients with asthma and active pulmonary tuber-
culosis. We also measured the serum IL-4, IFN- , TGF-
and IL-10 levels to investigate the impact of regulatory T
cells on the Th1 and Th2 immune status.
MATERIALS AND METHODS
Study subjects
Sixty two patients with chronic asthma (Table 1) before
treatment were recruited from the out-patient clinics of Soon-
chunhyang University Hospital. All of the patients exhibited
one or more symptoms of asthma, and their physical exami-
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Impact of Circulating TGF- and IL-10 on T Cell Cytokines in Patients
with Asthma and Tuberculosis
Regulatory T cells, which stimulate or inhibit the effector functions of distinct T cell
subsets, are critical in the control of the immune response. We investigated the
effect of TGF- and IL-10 on T cell subsets according to the Th1/Th2 immune sta-
tus. Sixty-two patients with asthma and 38 patients with pulmonary tuberculosis
were included. Allergy skin tests, tuberculin tests, and chest radiography were per-
formed. The levels of circulating IL-4, IFN- , TGF- 1, and IL-10 were measured
using ELISA. The level of TGF- 1 was higher in patients with asthma than in those
with tuberculosis, but the IL-10 levels were the same between the asthma and tuber-
culosis groups. Atopy was unrelated to the tuberculin response. The IFN- level
was correlated with the IL-10 level, and the level of IL-4 was unrelated to the IL-10
or TGF- 1 level. The level of IL-10 was higher in the negative tuberculin reactors
than in the positive tuberculin reactors among patients with asthma, and TGF- 1
was higher in the positive tuberculin reactors than in the negative tuberculin reac-
tors among patients with tuberculosis. These results demonstrate that the regula-
tory effects of circulating TGF- and IL-10 on T cell cytokines may be different
between Th2-type asthma and Th1 tuberculosis.
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nations were compatible with the American Thoracic Soci-
ety’s definition of asthma (7). Each patient showed airway
reversibility, as documented by a positive bronchodilator
response of a greater than 15% increase in FEV1 and/or air-
way hyperreactivity to less than 10 mg/mL methacholine (8).
Potential subjects who had less than a one-year duration of
asthma, acute exacerbated asthma within four weeks, a history
of brittle asthma, atopy to pollens, parenchymal lung disease
apparent on chest radiography, diffusing capacity of less than
80%, previous inhaled steroid or systemic steroid use within
the past four weeks, or maintenance theophylline or leuko-
triene antagonist therapies were excluded from the study.
Thirty-eight patients with pulmonary tuberculosis were
enrolled in the study (Table 1). The patients had respiratory
symptoms such as cough, sputum, fever, and chest discom-
fort. Pulmonary tuberculosis was diagnosed by chest roent-
genography and a positive acid-fast bacilli (AFB) stain. None
of the subjects took drugs, such as antihistamine, cromolyn,
theophylline, or sympathomimetics, that could interfere with
the performance of the skin tests within 72 hr of the tests.
The study subjects were not allowed to consume coffee or
tea on the day of the test. The blood samples were collected
at the same time as the diagnosis was made.
A control group was used in the study, and all of the study
and control group subjects had been vaccinated with BCG
during infancy or childhood, which was confirmed by the
presence of a vaccination scar. The study protocol was evalu-
ated and approved by the Ethics Committee of Soonchun-
hyang University Hospital, and informed written consent
was obtained from all of the study subjects.
Specimen collection and bacteriologic diagnosis for tuber-
culosis
Specimens of expectorated and induced sputa were collected
from patients with suspected tuberculosis infection. The
specimens were decontaminated, digested with N-acetyl-L-
cysteine-NaOH (4%) for 15 min at room temperature, and
neutralized with sterile 0.067 M phosphate-buffered saline
(pH 6.8). All of the specimens were subjected to Ziehl-Ni-
elsen staining for the detection of AFB.
Lung function tests
Baseline measurements of FVC and FEV1 were selected
according to the American Thoracic Society criteria (7). Basal
and post-bronchodilator FEV1, FVC, and FEF25-75% were
measured. Airway hyperreactivity was measured by metha-
choline challenge testing and expressed as the concentration
required to cause a fall in the FEV1 of 20% (PC20) in non-
cumulative units.
Allergy skin prick tests
Allergy skin prick tests were performed using commer-
cially available inhalant allergens, which included dust mites
(Dermatophagoides farinae and Dermatophagoides pteronyssinus,
Bencard Co., West Susses, U.K.) and histamine (1 mg/mL).
None of the subjects had received antihistamines orally dur-
ing the three days before the study. All of the tests included
positive (1 mg/mL histamine) and negative (diluent) controls.
After 15 min, the mean diameters of the wheals formed by
the allergens were compared with the ones formed by hista-
mine. If the former was the same or larger than the latter
(A/H ratio≥1.0), the reaction was deemed positive. Atopy
was determined by the presence of an immediate skin reac-
tion to one or more aeroallergens as described previously (9).
Tuberculin skin test
An area of the skin on the volar surface of the forearm was
cleaned with either acetone or ether. Two tuberculin units of
polysorbate-stabilized purified protein derivatives (PPD)
were injected intradermally into the volar surface of the fore-
arm. The reactions were read at 48-72 hr by palpating the
diameter of induration, which was measured in mm trans-
versely to the long axis of the forearm. The diameter of ery-
thema was not considered. If the diameter of the induration
was larger than 10 mm, the reaction was deemed positive.
Measurement of IL-4, IFN- , IL-10, and TGF- cytokine
levels
The serum levels of IL-4, IFN- IL-10, and TGF- were
quantified using a sandwich enzyme-linked immunosorbent
assay kit according to the manufacturer’s protocol (Biosource
International Inc., San Diego, CA, U.S.A.). The lower limits
of detection of IL-4, IFN- , IL-10, and TGF- 1 were 7.8 pg/
mL, 4.7 pg/mL, 7.8 pg/mL, and 62.5 pg/mL, respectively.
Statistical analyses
All data were analyzed using SPSS, version 7.5 for Win-
*Plus-minus values are mean±SEM. ND, not done; FEV1, forced expi-
ratory volume in one second; FVC, forced vital capacity; PC20, the provo-
cation concentration to cause a fall in FEV1 of 20%.
Asthma Control Tuberculosis
No. subjects 62 38 36
Age (yr)  41.2±2.0 37.5±2.9 35.7±3.4
Sex (M/F) 29/33 22/16 19/17
Duration of symptom (wk) 12±1.5 6±0.7
Atopy (%) 30.6 15.7 0
Tuberculin skin test (%) 53.2 63.1 0
FEV1, %predicted 86.2±3.15 ND ND
FEV1/FVC 76.0±1.52 ND ND
PC20 (mg/mL) 9.6±1.45 ND ND
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dows. The data were expressed as mean±standard error of
the mean (SEM). Mean values of measured variables were
compared between the three groups using one-way analysis
of variance. The relationships between cytokine levels were
tested by Spearman product moment correlation. A p-value
of <0.05 was considered significant.
RESULTS
The study included 62 patients with asthma, 38 patients
with pulmonary tuberculosis before treatment, and 36 con-
trol subjects (Table 1). All of the patients with pulmonary
tuberculosis had positive smears for AFB. The chest radio-
graphy abnormalities were located at the right upper lobe
in nine cases, left upper lobe in 11 cases, right lower lobe in
four cases, and multiple lobes in 14 cases. The PPD mean
induration size was 22.7±11.4 mm (range, 0-43 mm). In
the patients with tuberculosis, there were 24 cases of tuber-
culin reactors and six cases of atopy. The control group con-
sisted of subjects with a negative allergy skin test and nega-
tive tuberculin response without any respiratory symptoms
of tuberculosis or asthma.
The level of IFN- was higher in patients with pulmonary
tuberculosis than in those with asthma (30.3±10.56 pg/
mL vs. 7.4±2.77 pg/mL, p=0.04, Table 2), but IL-4 was
more prevalent in patients with asthma than in those with
tuberculosis (15/62 vs. 2/38, p=0.01). The level of IFN-
was higher in the pulmonary tuberculosis group than in the
control group. The level of TGF- 1 was higher in the asth-
ma group than in the tuberculosis and control groups (2977.9
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Fig. 1. Circulating cytokine profiles in patients with asthma by atopy (A) and tuberculin responses (B).
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*Plus-minus values are mean±SEM. *p<0.05 compared with tubercu-
losis patients. 
� p<0.05 compared with control group. 
� p<0.01 compared
with control group.
Asthma Control Tuberculosis
IL-4 (pg/mL) 12.5±8.78 3.2±0.62 2.3±1.88
IFN- (pg/mL) 7.4±2.77* 30.3±10.56
� 6.4±2.08
IL-10 (pg/mL) 11.1±2.33
� 16.4±3.22
� 4.96±1.15
TGF- 1 (pg/mL) 2977.9±824.23*,
� 941.5±164.54 1166.3±86.5
Table 2. Serum cytokine profiles in patients and control subjects
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Fig. 2. Circulating cytokine profiles in patients with pulmonary tuberculosis by atopy (A) and tuberculin responses (B).
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±824.2 pg/mL vs. 941.5±164.5 pg/mL vs. 1166.3±86.5
pg/mL, p<0.05, Table 2). The level of IL-10 was higher in
the asthma and tuberculosis groups than in the control group
(11.1±2.33 pg/mL vs. 16.4±3.22 pg/mL vs. 4.96±1.15
pg/mL, p<0.05, Table 2) but was similar between the asthma
and tuberculosis groups. There was no relationship between
atopy and the tuberculin response. The IFN- level corre-
lated with the IL-10 level (r=0.353, p<0.05). Although there
were no differences in the levels of IL-10 according to atopy,
IL-10 was higher in the negative tuberculin reactors than in
the positive tuberculin reactors among patients with asthma
(Fig. 1). IL-4 was higher in the negative tuberculin reactors
than in the positive tuberculin reactors among patients with
tuberculosis (Fig. 2). TGF- 1 was higher in the positive
tuberculin reactors than in the negative tuberculin reactors
among patients with tuberculosis (Fig. 2).
DISCUSSION
The IL-10 level was higher in the negative tuberculin reac-
tors than in the positive tuberculin reactors among patients
with asthma in this study; conversely, the level of TGF- 1
was higher in the positive tuberculin reactors than in the
negative tuberculin reactors among patients with tubercu-
losis. These results suggest that IL-10 and TGF- may reg-
ulate asthma and pulmonary tuberculosis by Th2 and Th1
immune status and that the regulatory effects of circulating
TGF- and IL-10 on T cells may be different between Th2-
type asthma and Th1-type tuberculosis.
The polarization of T-helper cells from T-helper 0 (Th0)
cells is regulated by dendritic cells, the strength of the anti-
gen stimulation, and the cytokines present during priming.
T-helper subsets can be distinguished by their cytokine pro-
files. Th1 cells mainly produce IL-2 and IFN- , and Th2
cells mainly produce IL-4, IL-5, and IL-10. The same cytokines
may also induce a shift in the balance between Th1 and Th2
responses. Through the release of particular cytokines, the
subsets may mutually modulate the response. For instance,
the release of IFN- by Th1 cells will inhibit the Th2 response,
and the release of IL-10 by Th2 cells will inhibit the Th1
response (10). Th2 cells represent a polarized form of the T
helper cell-mediated immune response characterized by the
production of IL-4, IL-5, IL-6, IL-9, IL-10, and IL-13, but
not IFN- and tumor necrosis factor- . By contrast, the other
polarized form of the T helper cell response, which is defined
as Th1, is characterized by the production of IL-2, IFN- ,
and TNF- , but not the cytokines of the Th2-type response
(11, 12). Asthma as an allergic disease develops early in life
(13). Infections appear to afford a protection against the devel-
opment of asthma and allergy (14), and children with eczema
occasionally undergo temporary, spontaneous remission after
severe bacterial and viral infections (15). Young adults who
had experienced measles in childhood were significantly less
likely to be atopic than those who had been vaccinated and/or
had never had measles (16). The BCG vaccine is a potent
immunoadjuvant for the induction of the Th1-type response
and increases the production of IFN- (17). In this study,
all of the patients had been vaccinated with BCG during
infancy or childhood. As all of the patients in this study were
adults, the effect of the BCG vaccine on the tuberculin res-
ponse was minimal.
It has been hypothesized recently that infections involving
a Th1 response will suppress the Th2 response based on the
concept of the Th1/Th2 balance comprising the dichotomy
in T helper cell populations through the mutual inhibition
of the Th1 and Th2 cell subset. Infections of the Th1-type,
such as Bordetella pertussis (18), Listeria monocytogenes (19),
Mycobacterium bovis (20), Leishmania (21), and many others,
induce an increased production of IFN- , which impairs the
Th2 response and thus reduces the progression of allergy/asth-
ma. Our findings that the IFN- level was higher in patients
with pulmonary tuberculosis than in those with asthma and
that IL-4 was more prevalent in patients with asthma than
in those with tuberculosis suggest that asthma is a Th2-medi-
ated disease and tuberculosis is a Th1-type disease. In our
study, a relationship between atopy and the tuberculin response
was not detected, which indicates that the Th1/Th2 paradigm
is not relevant as the explanation of all asthma and tubercu-
losis phenotypes and that the Th1/Th2 paradigm cannot be
the sole factor responsible for explaining the regulation of
asthma and allergy.
After the exposure of mice to allergen by the respiratory
route, regulatory CD4+ T cells developed, producing high
levels of IL-10, which is typically considered to be a Th2
cytokine. The Tr cells down-modulated allergen-induced
airway hyperreactivity in previously sensitized mice. Both
the development and function of Tr cells depend on the pres-
ence of IL-10 and the interaction with an inducible co-stim-
ulator expressed on dendritic cells. These dendritic cells also
express B7-1 and B7-2. Akbari et al. (22) suggested that IL-
10 may initially be involved in the polarization of Th2 res-
ponses and that it eventually plays a regulatory role late in
immune responses to attenuate Th2-driven inflammatory
activity. Although the level of IL-10 was higher in the asth-
ma and tuberculosis groups than in the control group, there
was no difference in the IL-10 level between the asthma and
tuberculosis groups, suggesting that IL-10 may be impor-
tant in the development of both asthma and tuberculosis,
rather than only in the attenuation of Th2-driven inflam-
matory activity. Also, IL-10 levels correlated with IFN- ,
which suggests that IL-10 levels may mirror those of IFN-
during the progression of airway diseases such as asthma and
tuberculosis.
TGF- is a pleiotropic cytokine produced by a variety of
cells and exerts its effects depending on the effector cell and
the context of production (23). The role of TGF- signaling in
T cells in immune regulation has been studied by impairing34 A.-S. Jang, S.-W. Park, M.-H. Ahn, et al.
TGF- signaling using dominant-negative TGF- type II
receptors (24, 25) or over-expression of Smad7, an inhibitory
Smad protein (26). TGF- acts on T cells to regulate airway
reactivity and inflammation. Depending on the mode of
immune stimulation, impaired TGF- signaling in T cells
modulates airway reactivity by the interaction of Th1 and
Th2 cytokines (27).
The level of TGF- 1 was higher in the asthma group than
in the tuberculosis and control groups, which indicates that
TGF- may be more involved in Th2-type asthma. The level
of TGF- 1 was higher in positive tuberculin reactors than
in negative tuberculin reactors among patients with tuber-
culosis, which regulate tuberculosis through a Th1 response.
The results presented in this study demonstrate that the
regulatory effects of circulating TGF- and IL-10 on T cell
subsets may be different between Th2-type asthma and Th1
tuberculosis.
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